WithdrawnNot Applicable

Cardiac 3D MRI in Pediatric Cancer Patients

Stopped: Slow accrual

United States0Started 2014-05

Plain-language summary

This is a non-randomized prospective pilot study in a single academic center with historic controls. This study will compare Cardiac Magnetic Resonance Images (MRI) of patients who have undergone childhood cancer treatment that has cardio-toxic effects to historic controls. The ultimate goal of this study is to develop a safe and effective method for early diagnosis of heart problems in children who are receiving chemotherapy treatments that may be toxic to the heart.

Who can participate

Age range8 Years – 26 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Childhood cancer treatment which has been completed * Received anthracyclines as part of childhood cancer treatment, at least 150 mg/m2 as cumulative dose * normal left ventricular systolic and diastolic functions on echocardiogram Exclusion Criteria: * Ongoing cancer treatment * Pregnancy * Inability to undergo a cardiac MRI * Abnormal ventricular systolic or diastolic function on echocardiogram

What they're measuring

Ventricular Function Measurement

Timeframe: Up to 2 years

Trial details

NCT IDNCT02130934

SponsorMajd Makhoul

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-03

View on ClinicalTrials.gov More Childhood Cancer trials